NCT06139510View on ClinicalTrials.gov

Predictors of Pain in Sickle Cell Disease

NARecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

July 12, 2024

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions
Sickle Cell DiseaseChronic Pain
Interventions
OTHER

Quantitative sensory testing

Quantitative sensory testing is a standard type of pain testing that measures changes in sensitivity to different type of sensations that include temperature, touch or pressure.

Trial Locations (1)

27710

RECRUITING

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Duke University

OTHER

NCT06139510 - Predictors of Pain in Sickle Cell Disease | Biotech Hunter | Biotech Hunter